Stay updated on Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision identifier in the footer changed from v3.7.2 to v3.8.0, reflecting a website release update.
    Difference
    0.1%
    Check dated 2026-10-29T08:54:28.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A notice was added explaining that NIH is transitioning to use “Super Intelligence” instead of “Artificial Intelligence,” and that both terms may appear during the transition.
    Difference
    0.7%
    Check dated 2026-10-22T08:20:46.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-15T11:13:48.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-08T12:59:23.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A new page revision tag (v3.7.0) was added to the record history, and the previous tag (v3.6.6) was removed, updating the history to reflect the latest version of the page.
    Difference
    0.1%
    Check dated 2026-09-17T19:12:18.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The study record history shows a new revision, v3.6.6, superseding the previous v3.6.5. This indicates the record was updated to a newer version.
    Difference
    0.1%
    Check dated 2026-09-03T18:46:55.000Z thumbnail image

Stay in the know with updates to Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.